Form 4: Lemaitre Vascular Director Martha Shadan Reports Acquisition of Dividend Equivalent Rights

Director Martha Shadan reports acquiring dividend equivalent rights related to restricted stock unit and performance share unit awards.

Summary

• On May 30, 2024, Martha Shadan, a director of Lemaitre Vascular Inc. (LMAT), acquired dividend equivalent rights related to previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
• These rights are economically equivalent to shares of LMAT common stock and vest proportionately with the underlying awards.
• Specifically, Shadan acquired 0.8146 dividend equivalent rights related to an RSU award granted on December 12, 2022, 0.8146 dividend equivalent rights related to a PSU award granted on December 12, 2022, and 1.0426 dividend equivalent rights related to an RSU award granted on December 8, 2023.
• Following these transactions, Shadan directly owns 6.7657, 5.777, and 2.2771 dividend equivalent rights respectively.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing simply reports the acquisition of dividend equivalent rights, which is a routine event.

Positives

• The acquisition of dividend equivalent rights suggests continued alignment of the director's interests with those of the shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of dividend equivalent rights by a director signals alignment with shareholder interests.

Key Dates